Carboxylic acid substituted oxazole derivatives for use as PPAR-alpha and - gamma activators in the treatment of diabetes

Details for Australian Patent Application No. 2002342244 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Maerki, Hans-Peter; Meyer, Markus; Mohr, Peter; Ricklin, Fabienne; Binggeli, Alfred; boehringer, Markus; Grether, Uwe; Hilpert, Hans

Agent Spruson & Ferguson

Pub. Number AU-B-2002342244

PCT Number PCT/EP02/04962

PCT Pub. Number WO2002/092084

Priority 01111745.4 15.05.01 EP

Filing date 6 May 2002

Wipo publication date 25 November 2002

Acceptance publication date 16 June 2005

International Classifications

A61K 031/421 - 1,3-Oxazoles, e.g. pemoline, trimethadione

C07D 263/22 Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings

C07D 413/12 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61K 031/422 - not condensed and containing further heterocyclic rings

A61P 003/10 Drugs for disorders of the metabolism

Event Publications

27 February 2003 Complete Application Filed

  Priority application(s): 01111745.4 15.05.01 EP

1 May 2003 Application Open to Public Inspection

  Published as AU-B-2002342244

16 June 2005 Application Accepted

  Published as AU-B-2002342244

13 October 2005 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002342245-CONVERSION OF TEXT DATA INTO A HYPERTEXT MARKUP LANGUAGE

2002342243-SPLIT FOUR STROKE ENGINE